Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nepafenac for Prevention of Cystoid Macular Edema after Cataract Surgery in Patients Receiving Latanoprost
TCTR20110000013Phase 3Recruiting
- Sponsor
- Glaucoma Research Foundation
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nepafenac in cystoid macular edema (CME), sponsored by Glaucoma Research Foundation. Started Dec 2010; status: recruiting.
02
Drugs
nepafenac
03
Conditions
cystoid macular edema (CME)
Beyond the preview
Go deeper on TCTR20110000013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20110000013.